Artificial Intelligence Assisted Insulin Titration System
Status:
Completed
Trial end date:
2020-04-15
Target enrollment:
Participant gender:
Summary
This is a single-center, open-labeled, parallel group, randomized controlled trial to access
the effect and safety of the Artificial Intelligence Assisted Insulin Titration System in
patients with Type 2 Diabetes Mellitus.